A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Biederman, Joseph; Melmed, Raun D; Patel, Anil; McBurnett, Keith; Konow, Jennifer; Lyne, Andrew; Scherer, Noreen

Biederman, Joseph; Melmed, Raun D; Patel, Anil; McBurnett, Keith; Konow, Jennifer; Lyne, Andrew; Scherer, Noreen.

Affiliation

Biederman J; Pediatric Psychopharmacology Department, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. jbiederman@partners.org

Pediatrics ; 121(1): e73-84, 2008 Jan.

Article in En | MEDLINE | ID: mdl-18166547

Subject(s)

Attention Deficit Disorder with Hyperactivity/drug therapy; Delayed-Action Preparations/administration & dosage; Guanfacine/administration & dosage; Adolescent; Attention Deficit Disorder with Hyperactivity/diagnosis; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Guanfacine / Delayed-Action Preparations Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Pediatrics Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google